ADIAL PHARMACEUTICALS, INC. 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-053907
- Form type
- 10-Q
- CIK
- 0001513525
- Primary document
- https://www.sec.gov/Archives/edgar/data/1513525/000121390026053907/ea0288762-10q_adial.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADIAL PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.0M | - | - |
| Net Income | $-2.0M | - | - |
| Eps Basic | -1.48 | - | - |
| Eps Diluted | -1.48 | - | - |
| Total Assets | $5.2M | - | - |
| Total Liabilities | $1.5M | - | - |
| Shareholders Equity | $3.7M | - | - |
| Operating Cash Flow | $-1.6M | - | - |